Cargando…

Intramuscular immunization of mice with live influenza virus is more immunogenic and offers greater protection than immunization with inactivated virus

BACKGROUND: Influenza virus continues to cause significant hospitalization rates in infants and young children. A 2-dose regime of trivalent inactivated vaccine is required to generate protective levels of hemagglutination inhibiting (HAI) antibodies. A vaccine preparation with enhanced immunogenici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harris, Katie, Ream, Rebecca, Gao, Jin, Eichelberger, Maryna C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123286/ https://www.ncbi.nlm.nih.gov/pubmed/21600020 http://dx.doi.org/10.1186/1743-422X-8-251

Ejemplares similares

Influenza and respiratory syncytial virus (RSV) vaccines for infants: Safety, immunogenicity, and efficacy
por: Beeler, Judy A., et al.
Publicado: (2013)

Comparison of the effectiveness of antibody and cell-mediated immunity against inhaled and instilled influenza virus challenge
por: Rivers, Katie, et al.
Publicado: (2013)

Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or Neuraminidase
por: Meseda, Clement A., et al.
Publicado: (2018)

NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
por: Krammer, Florian, et al.
Publicado: (2018)

Antibody Neutralization of an Influenza Virus that Uses Neuraminidase for Receptor Binding
por: Gentles, Lauren E., et al.
Publicado: (2020)

Potency under pressure: the impact of hydrostatic pressure on antigenic properties of influenza virus hemagglutinin
por: Eichelberger, Schafer L., et al.
Publicado: (2013)

Label‐free mass spectrometry‐based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines
por: Getie‐Kebtie, Melkamu, et al.
Publicado: (2012)

Immunogenicity and safety of an intramuscular split-virion quadrivalent inactivated influenza vaccine in individuals aged ≥ 6 months in India
por: Agarkhedkar, Sharad, et al.
Publicado: (2019)

Rapid Detection and Differentiation of Swine-Origin Influenza A Virus (H1N1/2009) from Other Seasonal Influenza A Viruses
por: Zhao, Jiangqin, et al.
Publicado: (2012)

Detergent-Mediated Virus Inactivation in Biotechnological Matrices: More than Just CMC
por: Farcet, Jean-Baptiste, et al.
Publicado: (2023)

Comparative immunogenicity analysis of intradermal versus intramuscular immunization with a recombinant human adenovirus type 5 vaccine against Ebola virus
por: Zhang, Zhe, et al.
Publicado: (2022)

Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination
por: Bhatnagar, Noopur, et al.
Publicado: (2023)

Immune cells: more than simple carriers for systemic delivery of oncolytic viruses
por: Eisenstein, Samuel, et al.
Publicado: (2014)

Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques
por: Chua, Brendon Y., et al.
Publicado: (2022)

Inactivation of Influenza Viruses with Heteropolyacids
por: Dalidchik, F. I., et al.
Publicado: (2022)

Immunization with 1976 swine H1N1‐ or 2009 pandemic H1N1‐inactivated vaccines protects mice from a lethal 1918 influenza infection
por: Easterbrook, Judith D., et al.
Publicado: (2011)

The digital version of JPIS offers more than ever
por: Kim, Tae-Il
Publicado: (2014)

Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines
por: Dong, Wei, et al.
Publicado: (2018)

Longitudinal Analysis of Neuraminidase and Hemagglutinin Antibodies to Influenza A Viruses after Immunization with Seasonal Inactivated Influenza Vaccines
por: Sergeeva, Mariia V., et al.
Publicado: (2023)

Mucosal and cellular immune responses elicited by nasal and intramuscular inoculation with ASFV candidate immunogens
por: Xu, Lulu, et al.
Publicado: (2023)

Enhanced Immunogenicity of a Whole-Inactivated Influenza A Virus Vaccine Using Optimised Irradiation Conditions
por: Singleton, Eve Victoria, et al.
Publicado: (2021)

EXPERIMENTAL TRANSMISSION OF INFLUENZA VIRUS INFECTION IN MICE : III. DIFFERING EFFECTS OF IMMUNITY INDUCED BY INFECTION AND BY INACTIVATED INFLUENZA VIRUS VACCINE ON TRANSMISSION ON INFECTION
por: Schulman, Jerome L.
Publicado: (1967)

Inactivation of Zika Virus by Photoactive Iodonaphthyl Azide Preserves Immunogenic Potential of the Virus
por: Austin, Amy L., et al.
Publicado: (2019)

Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert microenvironment and is sensitized by immunogenic viruses
por: Yan, Juan, et al.
Publicado: (2022)

THE INACTIVATION OF THE VIRUS OF EPIDEMIC INFLUENZA BY SOAPS
por: Stock, C. Chester, et al.
Publicado: (1940)

Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization
por: Bhide, Yoshita, et al.
Publicado: (2019)

Assessment of Immunogenicity of Adjuvanted Quadrivalent Inactivated Influenza Vaccine in Healthy People and Patients With Common Variable Immune Deficiency
por: Kostinova, Aristitsa Mikhailovna, et al.
Publicado: (2020)

Heterosubtypic Antiviral Activity of Hemagglutinin-Specific Antibodies Induced by Intranasal Immunization with Inactivated Influenza Viruses in Mice
por: Muramatsu, Mieko, et al.
Publicado: (2013)

Intramuscular Aripiprazole in the Therapy of Acute Mania for More than 24 hrs
por: Quante, Arnim, et al.
Publicado: (2019)

PROPAGATION OF INFLUENZA VIRUS IN "IMMUNE" ENVIRONMENTS
por: Magill, Thomas P.
Publicado: (1955)

ADJUVANTS IN IMMUNIZATION WITH INFLUENZA VIRUS VACCINES
por: Friedewald, William F.
Publicado: (1944)

IMMUNIZATION EXPERIMENTS WITH SWINE INFLUENZA VIRUS
por: Shope, Richard E.
Publicado: (1936)

Special Issue—Immunity to Influenza Viruses
por: Koutsakos, Marios, et al.
Publicado: (2022)

A Meta‐analysis of intradermal versus intramuscular influenza vaccines: Immunogenicity and Adverse Events
por: Marra, Fawziah, et al.
Publicado: (2012)

Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity
por: Hirvinen, Mari, et al.
Publicado: (2016)

Sublingual Vaccination with Live Influenza Virus Induces Better Protection Than Oral Immunization in Mice
por: Mao, Jie, et al.
Publicado: (2022)

Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay
por: Gao, Jin, et al.
Publicado: (2016)

Impact of Protein Nitration on Influenza Virus Infectivity and Immunogenicity
por: Dulin, Harrison, et al.
Publicado: (2022)

Preservation of the Immunogenicity of Dry-powder Influenza H5N1 Whole Inactivated Virus Vaccine at Elevated Storage Temperatures
por: Geeraedts, Felix, et al.
Publicado: (2010)

T189. PEPTIDE SHARING BETWEEN SCHIZOPHRENIA-RELATED PROTEINS AND THE INFLUENZA A VIRUS MAY OFFER A WINDOW INTO THE IMMUNE AETIOLOGY OF PSYCHOTIC DISORDERS
por: Kepinska, Adrianna, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eh9jj56cu1mb2iqglijs5lilo4